& SQSTM1↑ puncta (incl. short isoforms) and Nrf2–NQO1 detox pathway upregulation. This led to hepatomegaly with disrupted cellular architecture but no signs of early cancer as seen in other ATG KOs.
& SQSTM1↑ puncta (incl. short isoforms) and Nrf2–NQO1 detox pathway upregulation. This led to hepatomegaly with disrupted cellular architecture but no signs of early cancer as seen in other ATG KOs.